Cellectis Gets NIH Contract Worth $9.5M
October 16, 2012 - (Mass High Tech) - "Cellectis bioresearch Inc., the Cambridge-based subsidiary of Cellectis Group in Paris, has received a five-year contract worth up to $9.5 million from the National Institutes of Health (NIH) to develop stem cell technologies. Under the contract, Cellectis will generate clinical-grade, induced pluripotent stem (iPS) cells, which are stem cells created artificially from adult human cells." Read Full Article
